Fagan AM - Search Results

1

Neurodegenerative disease biomarkers Aβ_1-40, Aβ_1-42, tau, and p-tau₁₈₁ in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy.

Chen JA, Fears SC, Jasinska AJ, Huang A, Al-Sharif NB, Scheibel KE, Dyer TD, Fagan AM, Blangero J, Woods R, Jorgensen MJ, Kaplan JR, Freimer NB, Coppola G. Chen JA, et al. Among authors: fagan am. Brain Behav. 2018 Jan 13;8(2):e00903. doi: 10.1002/brb3.903. eCollection 2018 Feb. Brain Behav. 2018. PMID: 29484263 Free PMC article.

2

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM. Fagan AM, et al. Ann Neurol. 2006 Mar;59(3):512-9. doi: 10.1002/ana.20730. Ann Neurol. 2006. PMID: 16372280

3

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Fagan AM, et al. Arch Neurol. 2007 Mar;64(3):343-9. doi: 10.1001/archneur.64.3.noc60123. Epub 2007 Jan 8. Arch Neurol. 2007. PMID: 17210801

4

Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation.

Kauwe JS, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM, Holtzman DM, Morris JC, Goate AM. Kauwe JS, et al. Among authors: fagan am. Ann Neurol. 2007 May;61(5):446-53. doi: 10.1002/ana.21099. Ann Neurol. 2007. PMID: 17366635

5

Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.

Kauwe JS, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P, Galimberti D, Scarpini E, Morris JC, Fagan AM, Holtzman DM, Goate AM. Kauwe JS, et al. Among authors: fagan am. Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8050-4. doi: 10.1073/pnas.0801227105. Epub 2008 Jun 9. Proc Natl Acad Sci U S A. 2008. PMID: 18541914 Free PMC article.

6

Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.

Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, Goate AM. Kauwe JS, et al. Among authors: fagan am. Neurogenetics. 2009 Feb;10(1):13-7. doi: 10.1007/s10048-008-0150-4. Epub 2008 Sep 24. Neurogenetics. 2009. PMID: 18813964 Free PMC article.

7

Biomarkers of Alzheimer's disease.

Craig-Schapiro R, Fagan AM, Holtzman DM. Craig-Schapiro R, et al. Among authors: fagan am. Neurobiol Dis. 2009 Aug;35(2):128-40. doi: 10.1016/j.nbd.2008.10.003. Epub 2008 Oct 28. Neurobiol Dis. 2009. PMID: 19010417 Free PMC article. Review.

8

Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.

Cairns NJ, Ikonomovic MD, Benzinger T, Storandt M, Fagan AM, Shah AR, Reinwald LT, Carter D, Felton A, Holtzman DM, Mintun MA, Klunk WE, Morris JC. Cairns NJ, et al. Among authors: fagan am. Arch Neurol. 2009 Dec;66(12):1557-62. doi: 10.1001/archneurol.2009.279. Arch Neurol. 2009. PMID: 20008664 Free PMC article.

9

Cerebrospinal fluid biomarkers of Alzheimer's disease.

Fagan AM, Holtzman DM. Fagan AM, et al. Biomark Med. 2010 Feb;4(1):51-63. doi: 10.2217/BMM.09.83. Biomark Med. 2010. PMID: 20361010 Free PMC article. Review.

10

Exercise and Alzheimer's disease biomarkers in cognitively normal older adults.

Liang KY, Mintun MA, Fagan AM, Goate AM, Bugg JM, Holtzman DM, Morris JC, Head D. Liang KY, et al. Among authors: fagan am. Ann Neurol. 2010 Sep;68(3):311-8. doi: 10.1002/ana.22096. Ann Neurol. 2010. PMID: 20818789 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page